Klaassen C D, Waalkes M P, Cantilena L R
Environ Health Perspect. 1984 Mar;54:233-42. doi: 10.1289/ehp.8454233.
The effect of several chelating agents (diethyldithiocarbamic acid, DDC; nitrilotriacetic acid, NTA; 2,3-dimercaptopropanol, BAL; d,l-penicillamine, PEN; 2,3-dimercaptosuccinic acid, DMSA; ethylenediaminetetraacetic acid, EDTA; and diethylenetriaminepentaacetic acid, DTPA) on the toxicity, distribution and excretion of cadmium (Cd) was determined in mice. When chelators were administered immediately after Cd, significant increases in survival were noted after treatment with DMSA, EDTA, and DTPA. DTPA, followed by EDTA and then DMSA, were consistently the most effective in decreasing the tissue concentrations of Cd and increasing the excretion of Cd. NTA, BAL, DDC and PEN had no beneficial effects. The effects of increasing the time interval between Cd administration and initiation of chelation therapy was determined by using a single administration of DTPA, EDTA, and DMSA. Mice treated immediately after Cd administration excreted approximately 50% of the administered dose of Cd compared to 0.2% in controls. Treatment with chelator at later times significantly increased Cd excretion but the magnitude of the effect was much less than that seen in mice treated immediately after Cd. To determine the role of MT in the acute decrease in chelator efficacy following Cd poisoning, rats were injected IV with Cd followed by DTPA at various times after Cd. Although DTPA reduced Cd content in the various organs when given immediately after Cd, the chelator was ineffective at all later times. Increases in hepatic and renal metallothionein (MT) did not occur until 2 hr after Cd, and did not coincide with the earlier drop in chelator efficacy. Blockade of MT synthesis by actinomycin D failed to eliminate this decreased DTPA effectiveness. Therefore, it appears that MT does not play an important role in the acute decrease in efficacy of chelation therapy for Cd poisoning. The effect of repeated daily administration of chelators on the distribution and excretion of Cd was studied by administering chelators daily for 5 days starting 48 hr after Cd. DTPA, EDTA, DMSA and BAL significantly increased the urinary elimination of Cd. Thus, mobilization of Cd into urine occurs with repeated chelation therapy, which may decrease tissue concentrations of Cd and reduce the toxicity of the metal.
研究了几种螯合剂(二乙基二硫代氨基甲酸盐,DDC;次氮基三乙酸,NTA;2,3-二巯基丙醇,BAL;d,l-青霉胺,PEN;2,3-二巯基丁二酸,DMSA;乙二胺四乙酸,EDTA;以及二乙烯三胺五乙酸,DTPA)对小鼠体内镉(Cd)的毒性、分布和排泄的影响。当在给予镉后立即给予螯合剂时,用DMSA、EDTA和DTPA治疗后存活率显著提高。DTPA、其次是EDTA,然后是DMSA,在降低组织中镉浓度和增加镉排泄方面始终是最有效的。NTA、BAL、DDC和PEN没有有益作用。通过单次给予DTPA、EDTA和DMSA,确定了增加镉给药与螯合治疗开始之间的时间间隔的影响。镉给药后立即治疗的小鼠排泄了约50%的给药剂量的镉,而对照组为0.2%。在稍后时间用螯合剂治疗显著增加了镉的排泄,但效果的幅度远小于镉给药后立即治疗的小鼠。为了确定金属硫蛋白(MT)在镉中毒后螯合剂疗效急性下降中的作用,在镉注射后不同时间给大鼠静脉注射镉,随后注射DTPA。尽管在镉注射后立即给予DTPA可降低各器官中的镉含量,但在所有后续时间螯合剂均无效。肝脏和肾脏金属硫蛋白(MT)直到镉注射后2小时才增加,且与螯合剂疗效的早期下降不一致。放线菌素D阻断MT合成未能消除DTPA有效性的降低。因此,似乎MT在镉中毒螯合治疗疗效的急性下降中不起重要作用。通过在镉注射后48小时开始每天给予螯合剂5天,研究了重复每日给予螯合剂对镉的分布和排泄的影响。DTPA、EDTA、DMSA和BAL显著增加了镉的尿排泄。因此,重复螯合治疗可使镉动员到尿液中,这可能会降低组织中镉的浓度并降低金属的毒性。